Keywords: 10.2; 10.4; 36.1CT, computed tomography; DT, dominant tumor; PET, positron emission tomography; SN, secondary nodule
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: lung cancer; diagnostic test; biomarkers; prediction models; risk prediction; CT; computed tomography; EDTA; ethylenediaminetetraacetic acid; FDG; fluorodeoxyglucose; NPV; negative predictive value; NSCLC; non-small cell lung cancer; PET; positron emiss
Keywords: 8.4; 10.2; CT; computed tomography; EUS; endoscopic ultrasound; EUS-FNA; endoscopic ultrasound-guided fine needle aspiration; NSCLC; non-small cell lung cancer; TBNA; transbronchial biopsy; TTNA; transthoracic image-guided needle aspiration;
Keywords: 10.2; 10.4; 36.1CT, computed tomography; CXR, chest x-ray; MnDCT, minimal-dose computed tomography
Keywords: 10; 10.2; 10.4CT, computed tomography; FDG, fluorescence deoxyglucose; GGO, ground glass opacity; HU, Haunsfield unit; LC, lepidic component; LI, lymphatic invasion; OS, overall survival; PET, positron emission tomography; RFS, recurrence-free survival; S
Keywords: 10.2; CT; computed tomography; EBUS; endobronchial ultrasound; EBUS-TBNA; endobronchial ultrasound-guided transbronchial needle aspiration; EUS; endoscopic ultrasound; EUS-FNA; endoscopic ultrasound-guided fine needle aspiration; NSCLC; non-small cell l
Keywords: 10.1; 10.2; 10.4; 11.3; +; positive; â; negative; CSF-1; colony-stimulating factor-1; DFS; disease-free survival; IL-6; interleukin-6; NSCLC; non-small cell lung cancer; OS; overall survival; TAM; tumor-associated macrophage; TMA; tissue microarray;
Keywords: 10.2; 10.4; CT; computed tomography; FFP; fresh-frozen plasma; H&E; hematoxylin and eosin; HSA; human serum albumin; ICG; indocyanine green; NIR; near infrared; NSCLC; non-small cell lung cancer; PET; positron emission tomographic; SLN; sentinel lymph n
Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer
Keywords: stage III NSCLC; induction; surgery; CIR; cumulative incidence of recurrence; CT; computed tomography; DFS; disease-free survival; EBUS; endobronchial ultrasound; MSKCC; Memorial Sloan Kettering Cancer Center; NSCLC; non-small cell lung cancer; OS; over
High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds
Keywords: lung cancer; breath analysis; ATM; 2-(amino-oxy)-N, N, N trimethylethanammonium; CT; computed tomography; NLST; National Lung Screening Trial; 10; 10.2;
Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases
Keywords: 10.2; 10.4; CT; computed tomography; EBUS-TBNA; endobronchial ultrasound-guided transbronchial needle aspiration; NPV; negative predictive value; NSCLC; non-small cell lung cancer; PET; positron emission tomography; SUV; standardized uptake value; VATS;
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer
Keywords: 10.1; 10.2; 10.4; IGF; insulin-like growth factor; IGFBP; insulin-like growth factor binding protein; IL; interleukin; LDCT; low-dose computed tomography; MMP; matrix metalloproteinase; NSCLC; non-small cell lung cancer;
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer
Keywords: lung cancer surgery; neoadjuvant therapy; AOR; adjusted odds ratio; CDCC; Charlson/Deyo comorbidity condition; CI; confidence interval; HR; hazard ratio; IC; induction chemotherapy; ICR; induction chemoradiotherapy; NCDB; National Cancer Data Base; NSCLC;
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters
Keywords: 10.2; 36.1AIS, adenocarcinoma in situ; AUC, area under the curve; BAC, bronchioloalveolar carcinoma; CD, consolidation diameter; CEA, carcinoembryonic antigen; CT, computed tomography; GGO, ground-glass opacity; HU, Hounsfield unit; IASLC/ATS/ERS, Interna
Use of virtual assisted lung mapping (VAL-MAP), a bronchoscopic multispot dye-marking technique using virtual images, for precise navigation of thoracoscopic sublobar lung resection
Keywords: 10.2; 10.4; 15.5; 36.13D, 3-dimensional; CT, computed tomography; GGO, ground glass opacity; VATS, video-assisted thoracic surgery
Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?
Keywords: 10; 10.2; 13; 36FDG, fluorodeoxyglucose; HR, hazard ratio; NSCLC, non–small cell lung cancer; PET, positron emission tomography; SUV, standardized uptake value; SUVmax, maximum standardized uptake value
Lymphatic invasion predicts survival in patients with early node-negative non–small cell lung cancer
Keywords: 10.2; 10.4CT, computed tomographic; NSCLC, non–small cell lung cancer; TNM, tumor, nodes, and metastasis; UICC, Union for International Cancer Control; YSR, year survival rate
Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non–small cell lung cancer
Keywords: 10.2; 10.4; 13NSCLC, non–small cell lung cancer; TEMLA, transcervical extended mediastinal lymphadenectomy; VAMLA, video-assisted mediastinoscopic lymphadenectomy
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non–small cell lung cancer
Keywords: 10.2; 10.4; 36.1ACOSOG, American College of Surgeons Oncology Group; ASTRO, American Society for Therapeutic Radiology and Oncology; CT, computed tomography; EBUS, endobronchial ultrasound; FDG, fluorodeoxyglucose; NCCN, National Comprehensive Cancer Netw
Local recurrence after surgery for non-small cell lung cancer: AÂ recursive partitioning analysis of multi-institutional data
Keywords: 10.2; 10.4; CI; confidence interval; HR; hazard ratio; LR; local recurrence; LRFS; local recurrence-free survival; LVI; lymphovascular invasion; NSCLC; non-small cell lung cancer; RPA; recursive partitioning analysis;
Virtual endobronchial ultrasound for transbronchial needle aspiration
Keywords: CT; computed tomography; EBUS-TBNA; endobronchial ultrasound-guided transbronchial needle aspiration; PET; positron emission tomography; 3D; 3-dimensional; 10.2; 13; 15.5;
Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer?
Keywords: CT; computed tomography; EBUS; endobronchial ultrasound; TEMLA; transcervical extended mediastinal lymphadenectomy; VAMLA; video-assisted mediastinal lymphadenectomy; 10; 10.2; 10.4; 13;
Optimization of mediastinal staging in potential candidates for stereotactic radiosurgery of the chest
Keywords: 10; 10.2; CT; computed tomography; FM; fiducial marker; PET; positron emission tomography; EBUS; endobronchial ultrasonography; NSCLC; nonsmall-cell lung cancer; SBRT; stereotactic body radiotherapy; SRS; stereotactic radiosurgery; TBNA; transbronchial ne
Utility of endobronchial ultrasound–guided mediastinal lymph node biopsy in patients with non–small cell lung cancer
Keywords: 10; 10.2; 13CT, computed tomography; EBUS-TBNA, endobronchial ultrasound–guided transbronchial needle aspiration; L, level; LL, left level; NSCLC, non–small cell lung cancer; PET, positron emission tomography; RL, right level
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis
Keywords: 4.3; 10.2; 10.4ACE, Adult Co-Morbidity Evaluation; Dlco, carbon monoxide diffusion in the lung; FEV1, forced expiratory volume in 1 second; NSCLC, non–small cell lung cancer; PSM, propensity score matching; QALY, quality-adjusted life year; RTOG, Radiatio
Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non–small cell lung cancer
Keywords: 10.2; 10.4CI, confidence interval; CT, computed tomography; FEV1, forced expiratory volume in 1 second; HR, hazard ratio; NSCLC, non–small cell lung cancer; PET, positron emission tomography
Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma
Keywords: 10.1; 10.2; 14; 29BCD, benign chest disease; ILK, integrin-linked kinase; MCD, malignant chest disease other than malignant pleural mesothelioma; MPM, malignant pleural mesothelioma; SMRP, soluble mesothelin–related peptide
The utility of automated volumetric growth analysis in a dedicated pulmonary nodule clinic
Keywords: 10.2; 36.1CT, computed tomography; 2D, 2-dimensional; IPN, indeterminate pulmonary nodules; PET, positron emission tomography; PNC, pulmonary nodule clinic
Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis
Keywords: 10; 10.2; 10.4CI, confidence interval; HR, hazard ratio; LCSS, lung cancer-specific survival; NOS, not otherwise specified; NSCLC, non–small cell lung cancer; RT, radiotherapy; SCLC, small cell lung cancer; SEER, Surveillance, Epidemiology, and End Result
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial
Keywords: 10; 10.2; 10.4ACOSOG, American College of Surgery Oncology Group; CI, confidence interval; CT, computed tomography; MLND, mediastinal lymph node dissection; MLNS, mediastinal lymph node sampling; NSCLC, non–small cell lung cancer; VATS, video-assisted tho
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer
Keywords: 10; 10.2; 10.4; CP-EBUS; convex probe endobronchial ultrasound; CT; computed tomography; EBUS-TBNA; endobronchial ultrasound-guided transbronchial needle aspiration; EUS-FNA; endoscopic ultrasound-guided fine-needle aspiration; NSCLC; non-small cell lun